B's ability to deliver
potentially therapeutic genes in disease models.
Not exact matches
«My team at Nationwide Children's has worked with commitment and dedication to develop a therapy that may subsequently be shown through future clinical trials to
potentially alter the course of this unforgiving condition and provide a
therapeutic option for the families and infants with SMA1,» says Jerry Mendell, MD, principal investigator in the Center for
Gene Therapy at Nationwide Children's.
This technology helps researchers connect mutations in the so - called genomic «dark matter» with the
genes they affect,
potentially revealing new
therapeutic targets for genetic disorders.
Previous studies have linked
gene expression profiles in bCSCs with a clinical outcome [1, 2], and in this study the authors have extended this out to demonstrate that a DNA methylation profile may promote these changes, and furthermore, that this profile can be effectively used to predict prognosis, and
potentially aid the
therapeutic decision making.
To better understand UTIs and
potentially offer new
therapeutic strategies, a team of researchers analyzed 43 strains of E. coli sampled from 14 women with recurrent UTIs, and found that infection depends on both individual host susceptibility and how the bacteria express their
genes.
«We look forward to helping the company realize the tremendous promise of its
gene therapy platform, which has the potential to provide patients suffering from these severe eye diseases with treatments that offer life - long clinical benefits,
potentially based on a one - time
therapeutic administration.»